Skip to content
OpenCapital
Get started

Indivior Pharmaceuticals, Inc. INDV Investment Proceeds

Investment Proceeds at other companies

Alkermes logo
AlkermesALKS
$42.61M-62.5%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's investment proceeds?
Indivior Pharmaceuticals, Inc. (INDV) reported investment proceeds of $6M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's investment proceeds changed year-over-year?
Indivior Pharmaceuticals, Inc. 's investment proceeds decreased by 0.0% year-over-year, from $6M to $6M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's investment proceeds?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's investment proceeds has grown at a -11.1% compound annual growth rate (CAGR), from $27M to $19M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.